These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19717092)

  • 1. Is there a role for second-line chemotherapy in advanced gastric cancer?
    Wesolowski R; Lee C; Kim R
    Lancet Oncol; 2009 Sep; 10(9):903-12. PubMed ID: 19717092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.
    Jo JC; Lee JL; Ryu MH; Sym SJ; Lee SS; Chang HM; Kim TW; Lee JS; Kang YK
    Jpn J Clin Oncol; 2007 Dec; 37(12):936-41. PubMed ID: 18211985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Second-line treatment for metastatic or locally advanced gastric cancer].
    Li KC; Cheng SY; Du J; Li J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):721-724. PubMed ID: 27784452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
    Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer.
    Lim JY; Cho JY; Paik YH; Lee DK; Lee SI; Park HJ; Lee SJ; Lee KS; Yoon DS; Choi SH
    Oncology; 2007; 73(1-2):2-8. PubMed ID: 18332648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line chemotherapy for advanced gastric cancer in Korea.
    Baek SK; Kim SY; Jeong JH; Cho KS; Yoon HJ
    Gastric Cancer; 2012 Oct; 15(4):345-54. PubMed ID: 22410800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metastatic gastric cancer: does second-line chemotherapy make sense?].
    Breithaupt K; Thuss-Patience PC
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1872-6. PubMed ID: 20842609
    [No Abstract]   [Full Text] [Related]  

  • 8. Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer.
    Seo MD; Lee KW; Lim JH; Yi HG; Kim DY; Oh DY; Kim JH; Im SA; Kim TY; Lee JS; Bang YJ
    Jpn J Clin Oncol; 2008 Sep; 38(9):589-95. PubMed ID: 18772169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy for inoperable gastric cancer: current possibilities and perspectives of development].
    Volkov NM; Moiseenko VM
    Vopr Onkol; 2007; 53(4):383-92. PubMed ID: 17969398
    [No Abstract]   [Full Text] [Related]  

  • 10. Palliative chemotherapy for advanced gastric cancer.
    Wöhrer SS; Raderer M; Hejna M
    Ann Oncol; 2004 Nov; 15(11):1585-95. PubMed ID: 15520058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.
    Lee JL; Ryu MH; Chang HM; Kim TW; Yook JH; Oh ST; Kim BS; Kim M; Chun YJ; Lee JS; Kang YK
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):631-7. PubMed ID: 17520252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of advanced gastric cancer.
    Rivera F; Vega-Villegas ME; López-Brea MF
    Cancer Treat Rev; 2007 Jun; 33(4):315-24. PubMed ID: 17376598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of second-line chemotherapy for advanced gastric adenocarcinoma.
    Wilson D; Hiller L; Geh JI
    Clin Oncol (R Coll Radiol); 2005 Apr; 17(2):81-90. PubMed ID: 15830569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
    Pozzo C; Barone C
    Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis.
    Kim HS; Kim HJ; Kim SY; Kim TY; Lee KW; Baek SK; Kim TY; Ryu MH; Nam BH; Zang DY
    Ann Oncol; 2013 Nov; 24(11):2850-4. PubMed ID: 23942775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced disease and new drugs.
    Frustaci S; Buonadonna A; La Mura N; Berretta M; De Paoli A
    Suppl Tumori; 2003; 2(5):S48-50. PubMed ID: 12914391
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer.
    Farhat FS; Kattan J; Ghosn MG
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):541-8. PubMed ID: 20397919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic differences in approach to advanced gastric cancer: Is there a standard approach?
    Kim R; Tan A; Choi M; El-Rayes BF
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):416-26. PubMed ID: 23764501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
    Ciuleanu T; Stelmakh L; Cicenas S; Miliauskas S; Grigorescu AC; Hillenbach C; Johannsdottir HK; Klughammer B; Gonzalez EE
    Lancet Oncol; 2012 Mar; 13(3):300-8. PubMed ID: 22277837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.